Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24490,997,0.95 [0.83-1.09],0.4920092271060797
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24403,198,0.87 [0.65-1.16],0.3415674216108644
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26441,192,1.03 [0.76-1.39],0.8579233493590873
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18664,777,0.91 [0.78-1.06],0.2104752849537043
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26372,123,0.95 [0.66-1.38],0.7879449929193517
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25289,85,1.35 [0.86-2.12],0.1907231443445769
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27836,122,0.95 [0.66-1.37],0.7776645917610581
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27830,82,0.76 [0.49-1.18],0.2275815220231725
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24654,66,1.27 [0.76-2.13],0.3538029166245074
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27153,121,1.25 [0.86-1.81],0.2419709934506032
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27104,72,1.38 [0.85-2.24],0.1872045473258506
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27917,77,1.08 [0.67-1.73],0.7648746057978474
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27882,100,0.99 [0.66-1.50],0.9716596170054966
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27877,95,0.99 [0.65-1.52],0.9762072225862268
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,27529,65,0.85 [0.51-1.42],0.5397279578064644
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26704,441,0.90 [0.74-1.09],0.2741252745510903
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26395,132,0.67 [0.47-0.94],0.0222896453583314
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26569,306,0.95 [0.75-1.20],0.6794480110958363
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22838,52,1.11 [0.63-1.96],0.7115651882121697
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22850,64,nan [nan-nan],
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23049,263,nan [nan-nan],
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23056,270,nan [nan-nan],
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23461,675,0.97 [0.83-1.14],0.7222853013555408
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22839,53,1.14 [0.64-2.02],0.651756977484969
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25030,1045,1.22 [1.07-1.39],0.0031787006130956
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26826,294,0.99 [0.78-1.25],0.9249584953069164
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27570,110,1.09 [0.74-1.61],0.6605520690238974
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28014,90,0.89 [0.59-1.36],0.6036890065959767
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,27793,58,0.82 [0.49-1.39],0.4657570335896441
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28014,71,0.98 [0.61-1.58],0.9337085039435594
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Stomach,28061,56,1.29 [0.75-2.21],0.3557895713902193
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27833,277,1.09 [0.85-1.39],0.5170480979479595
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28009,112,1.17 [0.79-1.73],0.4415961947555223
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28008,105,0.96 [0.65-1.43],0.8549415295580933
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27939,71,2.01 [1.26-3.20],0.0035133174439141
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",27941,70,2.00 [1.25-3.20],0.0040038857228229
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,27846,272,0.97 [0.75-1.26],0.8329440362579251
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28020,123,0.99 [0.68-1.45],0.9546756561852848
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,27907,233,0.89 [0.68-1.17],0.4096668907907099
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of breast,27999,137,1.35 [0.95-1.93],0.0948942340757429
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,27478,1008,1.02 [0.90-1.17],0.7175458289443759
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26632,276,1.26 [0.98-1.62],0.0656003903033966
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26354,460,1.40 [1.15-1.71],0.0006886145975329
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26354,460,1.40 [1.15-1.71],0.0006886145975329
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24781,422,1.30 [1.06-1.59],0.0112859513807775
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27479,99,1.18 [0.78-1.80],0.4328864096608156
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27701,108,1.20 [0.80-1.78],0.3801259725102711
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23276,934,1.05 [0.92-1.21],0.4506398555125868
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25686,915,1.03 [0.90-1.18],0.6798937668597371
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26178,125,0.16 [0.12-0.22],1.2400360210628132e-33
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27035,62,1.10 [0.67-1.83],0.6977624834361795
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26164,111,0.15 [0.11-0.21],1.7223755604163438e-32
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26476,423,0.59 [0.49-0.71],4.808634172865212e-08
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26466,413,0.59 [0.49-0.72],1.078471894455729e-07
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25936,202,0.93 [0.69-1.25],0.6384121148571613
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25939,199,0.94 [0.70-1.26],0.6655849775365947
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23079,737,1.09 [0.93-1.27],0.2970173349846116
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22425,83,1.46 [0.93-2.30],0.0960843007918756
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,23026,684,1.08 [0.92-1.26],0.3664995194132907
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22392,50,0.89 [0.49-1.60],0.6955097538732156
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22415,73,1.38 [0.85-2.24],0.1958658855103363
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,23657,630,0.85 [0.72-1.00],0.0529958320350215
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23147,120,0.40 [0.29-0.56],9.572974909746321e-08
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27819,80,0.37 [0.25-0.54],2.455311952251963e-07
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27861,48,0.30 [0.19-0.47],1.3170121619698038e-07
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26589,38,0.37 [0.22-0.63],0.0002626486311321
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28011,38,0.38 [0.22-0.65],0.0004077684881941
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23065,38,0.37 [0.21-0.63],0.0002911280912228
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Alcohol dependence,26576,25,0.21 [0.13-0.35],2.4303867315075404e-09
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,26467,36,0.46 [0.24-0.87],0.0172458740236398
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23071,44,0.73 [0.39-1.35],0.3099567604290891
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23416,389,0.89 [0.72-1.10],0.2696186366613997
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Depression,26018,345,0.81 [0.65-1.01],0.0621613709630467
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,23195,303,0.75 [0.59-0.95],0.0172735822108286
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23179,152,1.30 [0.93-1.82],0.1273857939706114
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,26102,77,1.12 [0.70-1.79],0.638374952886767
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,24181,1656,0.91 [0.82-1.01],0.0828571370426309
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22114,184,0.60 [0.44-0.81],0.0008962034955639
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27861,153,0.56 [0.41-0.77],0.0002620111819629
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26700,433,0.94 [0.77-1.14],0.5120595222795719
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,26408,141,0.68 [0.49-0.95],0.0255555887849195
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,26398,131,1.36 [0.95-1.95],0.0957695336701352
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27612,121,1.40 [0.96-2.03],0.0764513706391674
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27346,60,1.65 [0.99-2.74],0.0543947522819124
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,26366,99,0.73 [0.49-1.07],0.1084636805634561
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,27635,71,0.88 [0.55-1.40],0.5796642530286121
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26654,871,1.05 [0.91-1.21],0.5033222299132487
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25905,122,0.85 [0.59-1.24],0.4088468831652766
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26337,554,1.08 [0.91-1.29],0.3907124031360631
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27797,77,0.45 [0.30-0.66],4.9459460159017534e-05
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,27777,57,0.40 [0.26-0.62],3.173034022621477e-05
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,27559,126,0.85 [0.59-1.22],0.3801097957547552
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27307,431,0.95 [0.78-1.16],0.6113803961636839
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27130,254,1.07 [0.83-1.38],0.6068893860508943
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26948,72,0.64 [0.40-1.03],0.0639796836290107
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27014,138,0.98 [0.70-1.40],0.9320251756709738
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26982,106,1.02 [0.69-1.52],0.9154809951411164
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23852,177,1.10 [0.81-1.49],0.5510939593167214
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,24094,419,1.02 [0.84-1.25],0.8311408489357175
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26992,189,0.68 [0.51-0.91],0.0089828884389319
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27786,36,0.31 [0.20-0.48],2.0896535386038237e-07
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1812,36,0.61 [0.40-0.93],0.0209616118113751
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26010,36,0.24 [0.14-0.41],1.1568993498781748e-07
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27341,97,1.38 [0.91-2.09],0.1243499227087716
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27298,54,1.27 [0.73-2.21],0.3956539036549999
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27204,98,0.77 [0.51-1.16],0.2114777810226962
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27473,105,1.15 [0.77-1.71],0.4991893937331586
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27935,133,0.98 [0.68-1.39],0.892851426383028
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27248,106,1.32 [0.89-1.95],0.1739989446116679
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20653,2857,1.08 [0.99-1.18],0.0984535204844083
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27473,77,1.60 [1.01-2.53],0.0432579778152741
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21687,2104,1.02 [0.92-1.12],0.7683013305908774
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,21709,2126,1.05 [0.95-1.16],0.3450398835772484
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19635,52,6.31 [4.14-9.63],1.276215737895561e-17
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26344,746,1.22 [1.05-1.42],0.0102374567908779
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,26115,517,1.13 [0.95-1.36],0.1685479942345898
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27375,151,1.17 [0.85-1.62],0.3327942536595991
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27457,233,1.28 [0.99-1.66],0.0644487128951744
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27989,28,0.99 [0.47-2.07],0.9717737334156248
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25698,100,1.52 [1.02-2.27],0.0389013432161508
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26077,491,1.22 [1.02-1.47],0.0293773606389583
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27262,100,1.01 [0.67-1.50],0.9763269351351348
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27364,219,0.87 [0.66-1.14],0.2993130275041157
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27259,97,1.62 [1.08-2.43],0.0203502029501179
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27259,97,1.62 [1.08-2.43],0.0203502029501179
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19677,94,1.63 [1.07-2.51],0.0244317820745753
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24360,40,3.42 [2.05-5.71],2.6696883782645856e-06
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,24401,81,1.66 [1.07-2.59],0.0246120213038292
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16832,104,1.02 [0.67-1.58],0.9121106924127972
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17012,284,1.47 [1.13-1.90],0.0035276561558764
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,24373,53,1.08 [0.62-1.89],0.784262626356899
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24379,59,1.83 [1.10-3.05],0.0205955301582013
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27193,105,1.90 [1.31-2.76],0.0007693997559699
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27259,129,1.28 [0.90-1.83],0.1745390015103566
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27301,97,1.50 [1.00-2.24],0.0502505326780714
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27371,85,1.25 [0.81-1.93],0.3233803616076184
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27059,72,1.59 [0.98-2.56],0.0593011294024206
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27104,117,1.51 [1.04-2.20],0.0297571749091616
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26408,133,0.78 [0.55-1.10],0.1585995675301089
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26381,106,0.84 [0.57-1.24],0.3788231058370249
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27845,103,0.82 [0.56-1.22],0.3341982017672446
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,26889,614,0.88 [0.74-1.05],0.1486258163557255
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,26894,95,1.15 [0.75-1.75],0.5254963805105343
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22797,2141,0.97 [0.88-1.07],0.5385382415171291
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27842,129,1.18 [0.82-1.70],0.3667222846965069
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26380,202,1.51 [1.13-2.02],0.0052519864898366
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26360,182,1.57 [1.16-2.13],0.0033599996790661
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27131,234,0.76 [0.59-0.99],0.043086511233791
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27123,226,0.74 [0.57-0.97],0.0278419437357127
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27276,571,0.95 [0.80-1.13],0.578850795283775
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26820,115,1.16 [0.79-1.70],0.4577835189790288
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,26787,82,1.23 [0.79-1.94],0.3616788913600514
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27065,360,0.89 [0.72-1.11],0.2996003753342108
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26847,142,1.41 [1.00-1.99],0.0506316505192462
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13512,66,0.66 [0.39-1.13],0.133323140150783
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25044,1184,0.98 [0.87-1.11],0.7316769889351012
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,26977,162,0.80 [0.59-1.10],0.1691554553939825
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26997,182,0.89 [0.66-1.19],0.4268242788591637
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26997,182,0.89 [0.66-1.19],0.4268242788591637
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25966,1017,0.96 [0.85-1.10],0.5576930933945484
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Asthma,20830,1017,0.94 [0.82-1.08],0.3875422585260967
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20635,1017,0.94 [0.82-1.08],0.3678149705361326
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20814,1001,0.94 [0.82-1.08],0.3788176219898254
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27728,84,1.69 [1.10-2.60],0.0165396829325075
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26230,63,1.94 [1.18-3.18],0.0089485259760619
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27805,63,1.91 [1.17-3.12],0.00974423589409
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26223,56,1.82 [1.07-3.09],0.0263538147453223
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,26175,89,1.05 [0.68-1.62],0.833620780709275
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,26282,196,1.25 [0.93-1.67],0.1437708870897161
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26865,94,1.39 [0.92-2.10],0.1206485667627645
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19401,6105,0.90 [0.84-0.96],0.001460856936052
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27480,482,0.90 [0.74-1.08],0.2572604893781341
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28015,108,1.09 [0.72-1.64],0.6968947017421611
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,28020,97,1.02 [0.66-1.59],0.9194180839396268
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,27106,108,0.85 [0.58-1.25],0.4140641811795076
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27118,120,0.84 [0.58-1.23],0.370908057182346
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28005,119,1.08 [0.73-1.60],0.7028043691686849
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27116,118,0.90 [0.62-1.31],0.5786513892062234
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26810,81,0.72 [0.46-1.12],0.1437347417539139
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27924,51,0.99 [0.56-1.76],0.982540070348726
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21191,220,1.01 [0.76-1.33],0.9602793840661932
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23328,2357,0.92 [0.84-1.01],0.0669286522891541
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,21267,296,0.79 [0.62-1.00],0.0541327244111818
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21724,753,0.82 [0.70-0.96],0.0116312882690381
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21047,76,1.11 [0.69-1.79],0.6611168230618121
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21108,137,1.03 [0.73-1.47],0.8523242995956922
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21011,40,0.97 [0.51-1.84],0.925969309102004
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,21116,145,1.10 [0.78-1.55],0.5839714982436597
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,21047,76,0.87 [0.55-1.40],0.569465832470242
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27968,54,0.99 [0.57-1.70],0.9578676959212044
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,21105,134,1.35 [0.95-1.92],0.0919239690962311
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21831,860,1.02 [0.89-1.18],0.7583658825091992
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,27889,149,0.87 [0.61-1.22],0.4088264763892594
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21557,586,0.94 [0.79-1.11],0.4569573352691968
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21151,180,0.71 [0.52-0.96],0.0262990600298542
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27926,144,0.81 [0.58-1.14],0.2305382092923996
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,27859,119,0.83 [0.56-1.21],0.3218847218152851
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,25100,1218,0.90 [0.79-1.01],0.0755346430206139
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,23949,67,1.06 [0.64-1.76],0.8293094440116738
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,23954,72,1.06 [0.66-1.70],0.8135873430408966
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,23993,111,0.84 [0.57-1.24],0.3848841195785719
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24856,974,0.87 [0.76-1.00],0.0482949357471278
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26955,923,0.71 [0.62-0.82],9.617624397283148e-07
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22207,2224,0.90 [0.82-0.99],0.0336583318342398
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27702,63,1.00 [0.58-1.70],0.9904167310563792
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27985,91,0.59 [0.39-0.88],0.0102228293895489
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,26123,91,0.56 [0.37-0.86],0.0072810003622782
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26098,66,0.54 [0.33-0.88],0.0124566712417033
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27906,133,0.59 [0.42-0.82],0.0016706410185375
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26165,133,0.57 [0.41-0.80],0.0011664507548893
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26151,119,0.58 [0.40-0.82],0.0024400275869145
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26815,783,0.71 [0.61-0.82],4.126735605861129e-06
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26806,774,0.72 [0.62-0.84],1.4271963751108725e-05
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20091,108,1.16 [0.77-1.74],0.4840889826808373
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal stricture,27572,108,1.19 [0.80-1.76],0.4007056587765277
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20050,67,1.15 [0.68-1.93],0.6038750222432677
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20667,684,0.85 [0.73-1.00],0.0546952663938001
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20232,249,0.86 [0.66-1.13],0.2786656297428678
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20383,400,0.85 [0.69-1.05],0.1403383389080175
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,26309,357,0.86 [0.69-1.08],0.1919818578289939
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27526,127,0.94 [0.65-1.36],0.7518331359455002
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,20110,127,0.74 [0.50-1.08],0.1218475351297926
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,20030,47,0.92 [0.50-1.72],0.80097802479744
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20888,905,0.99 [0.86-1.14],0.8621704159940631
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,20218,235,0.80 [0.61-1.04],0.1005914001827934
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27508,109,1.05 [0.71-1.56],0.8004458765731772
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,27245,107,0.71 [0.49-1.03],0.0734975822110767
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,27192,54,0.64 [0.38-1.09],0.0993852454088576
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26450,891,0.95 [0.83-1.10],0.5100407022968294
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,26304,745,1.01 [0.87-1.17],0.929401667658865
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,25693,134,0.80 [0.56-1.13],0.2035228707651712
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25629,70,0.66 [0.41-1.06],0.0855973038975608
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25621,62,0.85 [0.52-1.41],0.5311719612658341
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27895,62,0.86 [0.52-1.42],0.5521465538135657
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26637,313,0.93 [0.73-1.17],0.530784078835841
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26429,105,0.71 [0.51-0.99],0.0409720188462351
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,26413,89,0.76 [0.49-1.17],0.2165274320711178
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26365,41,0.71 [0.38-1.33],0.2864168828521007
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26496,172,1.02 [0.75-1.39],0.9007258915182084
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,26486,162,1.07 [0.77-1.47],0.687007431068178
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24822,1648,0.91 [0.82-1.02],0.0931003896431383
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27580,115,0.90 [0.62-1.32],0.6008883161476237
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27587,466,0.96 [0.79-1.16],0.6779796097303328
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26445,711,0.92 [0.79-1.08],0.3043934388227786
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27214,328,1.18 [0.94-1.47],0.1572364069608113
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26956,70,0.89 [0.55-1.45],0.6401274366472925
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27096,210,1.35 [1.02-1.78],0.032859751991788
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27760,93,0.68 [0.45-1.01],0.0565937933646443
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27733,66,0.64 [0.40-1.02],0.058405892400819
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27719,52,0.71 [0.41-1.21],0.2095915179617046
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27777,55,0.45 [0.29-0.71],0.0005904038044919
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27774,52,0.45 [0.28-0.72],0.0009016980970056
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27180,59,1.23 [0.73-2.08],0.4309282407039113
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27485,364,0.98 [0.79-1.22],0.8439166638183695
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25840,106,1.11 [0.74-1.66],0.6102833283674642
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25894,160,0.55 [0.41-0.75],0.0001054352060355
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25850,116,0.48 [0.35-0.68],2.073943922299564e-05
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25994,260,1.00 [0.78-1.30],0.9709229469449712
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25968,234,1.03 [0.79-1.36],0.8172702391795443
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19756,4479,1.00 [0.93-1.07],0.992494551652129
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21530,2580,0.98 [0.90-1.07],0.7108080830368567
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25177,1352,0.90 [0.81-1.01],0.0849794907873661
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19163,213,1.01 [0.76-1.34],0.9503099460835452
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19478,528,0.96 [0.80-1.15],0.6892406730473679
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27465,204,0.95 [0.72-1.27],0.7530082625703025
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27482,186,1.04 [0.77-1.40],0.8198554808885838
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20205,1255,0.98 [0.87-1.11],0.7409650712399867
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22960,1255,0.97 [0.86-1.10],0.6525550401735578
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18963,13,0.60 [0.21-1.67],0.3249185023427194
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27847,13,0.62 [0.23-1.71],0.3597064880553164
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19235,285,0.87 [0.68-1.11],0.2530144121215538
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19039,89,0.70 [0.46-1.06],0.0935725411803333
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19263,313,1.05 [0.83-1.32],0.7040854143322446
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27854,159,0.83 [0.61-1.14],0.2488294005588724
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19442,492,0.93 [0.77-1.12],0.4638591520969353
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19451,501,0.94 [0.78-1.13],0.4830103704253959
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20393,1443,0.95 [0.85-1.07],0.3971746005051894
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19059,109,0.60 [0.41-0.88],0.0093878775389882
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19381,431,0.96 [0.78-1.18],0.6983113870298159
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,19034,84,1.13 [0.72-1.78],0.6018344019020221
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19057,107,1.05 [0.71-1.57],0.7941506826844666
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19328,378,0.95 [0.77-1.18],0.6618033146791849
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19271,321,0.90 [0.71-1.13],0.3667154396015105
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20903,302,0.81 [0.64-1.03],0.0829392925734291
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27214,223,1.51 [1.15-1.99],0.0032596200120086
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27086,95,1.17 [0.77-1.79],0.4527458885513162
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24006,82,0.74 [0.48-1.16],0.1929215164506929
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24234,310,0.91 [0.72-1.15],0.4239656315101542
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24967,1043,0.92 [0.81-1.05],0.2386334237296997
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24144,220,1.00 [0.76-1.32],0.9829851867750288
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24001,77,0.65 [0.42-1.01],0.0566935373183488
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24757,833,0.91 [0.78-1.05],0.1920540085474187
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23977,53,0.86 [0.48-1.51],0.5884014901408141
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24171,247,0.85 [0.66-1.11],0.2407944827382431
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24029,105,0.75 [0.50-1.13],0.1698440740047689
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24017,93,0.66 [0.44-1.00],0.0475936761237138
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24089,165,1.10 [0.79-1.52],0.581906901142859
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24001,77,0.79 [0.50-1.25],0.3146445383865588
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24284,360,0.92 [0.74-1.14],0.4518998603220575
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24216,391,1.08 [0.87-1.34],0.4724998708719843
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23900,75,0.87 [0.54-1.39],0.5518832772666733
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23937,112,1.28 [0.87-1.89],0.2114951975415593
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23969,144,1.20 [0.85-1.70],0.3009334909822519
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23864,39,0.73 [0.37-1.42],0.3497789461416667
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23884,59,0.63 [0.37-1.07],0.0883912074902325
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23868,43,0.67 [0.35-1.26],0.2084927992135955
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24106,281,0.72 [0.57-0.92],0.0091941933860372
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23884,59,0.70 [0.41-1.17],0.1712028863911651
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23895,70,0.63 [0.40-1.01],0.0558430364236603
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23964,139,0.83 [0.58-1.17],0.2845961431129721
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23908,83,0.67 [0.42-1.05],0.0808338185074779
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24368,543,0.94 [0.79-1.13],0.5316078812932596
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24018,193,1.08 [0.80-1.46],0.6009827149240266
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24118,293,0.89 [0.70-1.13],0.3396030214995906
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25254,241,0.97 [0.75-1.27],0.8311472465113197
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25505,492,0.95 [0.79-1.15],0.606448899564604
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25051,38,0.90 [0.46-1.75],0.756907304315557
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25080,67,0.68 [0.41-1.11],0.12421752165494
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25131,118,0.88 [0.60-1.30],0.5249601009715572
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22885,6217,1.00 [0.94-1.07],0.9563235245906778
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25540,207,2.62 [2.02-3.41],6.649939320615555e-13
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25379,46,2.00 [1.10-3.65],0.0230372043874972
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25711,38,3.63 [2.13-6.18],1.982459433158753e-06
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25722,49,6.88 [4.60-10.27],5.030519697802818e-21
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25717,44,3.67 [2.24-6.04],2.7967504364205e-07
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27805,135,0.92 [0.65-1.31],0.6599640750050753
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27678,69,2.21 [1.40-3.49],0.0007068658059033
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27772,102,1.00 [0.66-1.50],0.9947000580539088
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27708,38,0.82 [0.42-1.58],0.5500317474283734
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25782,1275,0.91 [0.80-1.02],0.1036812656445967
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,24645,138,1.40 [0.99-1.99],0.0600590493088208
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24591,84,0.82 [0.53-1.28],0.3822789672683909
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24680,173,1.08 [0.79-1.48],0.617678243490972
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24598,91,1.13 [0.73-1.74],0.5904341257019313
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25513,1006,0.88 [0.77-1.00],0.0584737211242858
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27734,483,0.97 [0.80-1.17],0.7657224601812848
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27401,150,1.28 [0.92-1.80],0.1476127117368117
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27420,169,0.88 [0.64-1.21],0.4273599364165186
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27366,115,0.95 [0.64-1.39],0.7803804634145256
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27669,567,0.97 [0.81-1.16],0.740703954661179
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27238,136,0.71 [0.50-1.01],0.0538041732089788
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27355,253,1.21 [0.92-1.57],0.1687475382049121
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25573,4649,0.96 [0.90-1.03],0.2927297444919099
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21291,367,1.20 [0.96-1.50],0.1104294935949138
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,21023,99,1.17 [0.75-1.81],0.4834117679374957
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21094,170,1.19 [0.87-1.65],0.2764128129123192
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21730,806,0.85 [0.73-0.98],0.0244615928789979
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21338,414,1.01 [0.82-1.25],0.8962945240590615
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21897,973,0.99 [0.87-1.14],0.9327957418912834
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21241,317,1.02 [0.81-1.29],0.8458518176675377
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21370,446,0.89 [0.73-1.08],0.2475625900957606
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,21027,103,1.03 [0.67-1.58],0.8910849025845473
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21115,191,1.09 [0.80-1.48],0.5830283042885478
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",28012,269,1.09 [0.84-1.41],0.5150249091272249
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,28024,255,1.09 [0.84-1.42],0.5243769102962524
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,28051,140,1.29 [0.90-1.84],0.1654222973136689
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",28040,154,1.26 [0.90-1.77],0.1861088837155333
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21071,147,0.98 [0.70-1.38],0.9184586401313524
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21041,117,0.99 [0.68-1.45],0.9607826854021946
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21067,143,0.77 [0.54-1.08],0.1282449054098363
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27943,473,0.95 [0.78-1.15],0.6020200576468704
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22276,1352,0.97 [0.86-1.10],0.6555268047430366
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21803,879,0.99 [0.86-1.15],0.9025137798734004
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",28031,199,0.89 [0.66-1.20],0.4604313033866909
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21392,468,0.84 [0.69-1.02],0.0736308432779373
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21258,334,0.85 [0.67-1.07],0.1603501958768528
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21831,907,1.08 [0.94-1.24],0.2826210065170206
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female infertility,21041,117,1.64 [1.08-2.49],0.0214465569945222
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",21034,110,1.71 [1.11-2.64],0.0145453582911368
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,28047,882,1.24 [1.05-1.47],0.0097345323670802
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,28051,1205,1.13 [0.98-1.31],0.1007456525337529
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,28048,486,1.03 [0.84-1.27],0.7765032973341193
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27699,137,0.81 [0.55-1.18],0.2662984037164404
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27755,193,1.22 [0.88-1.69],0.2324869303444099
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27732,170,1.17 [0.83-1.63],0.3674649787072094
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",28068,167,1.40 [0.99-1.98],0.0573297107434318
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,28070,164,1.37 [0.97-1.95],0.0738991796261949
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,28066,423,1.08 [0.87-1.35],0.4810610011597989
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27770,127,1.16 [0.78-1.72],0.4757751524795919
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27875,232,0.99 [0.73-1.33],0.9466648269684887
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27315,150,1.38 [0.95-2.02],0.0917739549343748
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27366,201,1.52 [1.10-2.09],0.010954972271784
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27413,248,1.16 [0.87-1.55],0.3155831919188891
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27314,149,1.20 [0.82-1.75],0.3515781676109437
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27305,140,1.35 [0.92-1.98],0.1237595067680052
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27317,152,0.95 [0.66-1.37],0.7779522685618255
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,27077,231,1.03 [0.76-1.40],0.8327904386581324
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27287,441,1.20 [0.96-1.50],0.1113500486584756
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27521,675,1.15 [0.95-1.39],0.1534868823223517
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",28070,170,1.18 [0.83-1.68],0.3441730178764712
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26602,129,1.29 [0.87-1.92],0.2035407916211299
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26950,104,1.50 [0.95-2.36],0.0800745500255144
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,28078,344,0.97 [0.76-1.24],0.8032254168406621
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27997,263,0.95 [0.71-1.26],0.707953210154523
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",28065,256,1.16 [0.87-1.54],0.3156256917232714
PLA2G1B,Phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",28055,246,1.15 [0.86-1.54],0.3459037921274673
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27766,44,2.36 [1.35-4.11],0.0024352977801429
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,25112,658,0.77 [0.66-0.91],0.0016463472013036
